Previous close | 37.45 |
Open | 37.45 |
Bid | 39.10 |
Ask | 42.20 |
Strike | 82.50 |
Expiry date | 2025-01-17 |
Day's range | 37.45 - 37.45 |
Contract range | N/A |
Volume | |
Open interest | 34 |
PRINCETON, N.J., June 03, 2024--BMS' Breyanzi Demonstrates Clinically Meaningful Outcomes Across Broad Range of B-Cell Malignancies in New Data Presented at 2024 ASCO® Annual Meeting
PRINCETON, N.J., June 03, 2024--Bristol Myers Squibb Presents Multiple New Analyses at 2024 ASCO® Annual Meeting Highlighting Opdivo and Opdivo-based Combinations...
PRINCETON, N.J., June 01, 2024--KRAZATI (adagrasib) Demonstrated Statistically Significant Improvement in Progression-Free Survival in Patients with Pretreated Locally Advanced....